36.19USD-1.82%Mkt Cap: 1.90B $P/E: —Today
Immunocore Holdings plc, together with its subsidiaries, engages in the development and commercialization of immunomodulating medicines for patients with cancer, infectious diseases, and autoimmune disease in the United …
Industry Peers
Biotechnology$130.23BUSDP/E 32.1
$139.84BUSDP/E 32.2
$85.11BUSDP/E 20.4
$69.62BUSD
$61.34BUSDP/E 39.8
$45.95BUSDP/E 19.6
$46.01BUSD
$41.76BUSDP/E 66.2
$35.67BUSDP/E 33.2
$32.46BUSDP/E 42.3
$28.53BUSD
$26.14BUSD
$25.79BUSDP/E 16.2
$20.83BUSDP/E 26.3
$19.26BUSDP/E 26.6
$17.03BUSDP/E 20.0
$16.41BUSD
$13.48BUSDP/E 17.1
$13.42BUSDP/E 187.4
$12.87BUSDP/E 264.5
Key Statistics
Company
Market Cap1.90B $
Enterprise Value1.43B $
Revenue (TTM)430.78M $
Gross Profit394.93M $
Net Income (TTM)-35.51M $
Revenue/Share8.499 USD
Last Price36.19 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees524
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINUS45258D1054
Valuation
P/E (Trailing)—
P/E (Forward)-48.63
PEG—
EV/EBITDA1888.56
EV/Revenue3.31
P/S4.34
P/B4.45
EPS (TTM)-0.36
EPS (Forward)-0.75
52W Range
33.9364% of range37.44
52W High37.44 USD
52W Low33.93 USD
Profitability
Gross Margin98.73%
Oper. Margin-2.58%
EBITDA Margin0.17%
Profit Margin-8.88%
ROE-9.32%
ROA-3.33%
Growth
Revenue Growth18.30%
Earnings Growth—
Cash Flow & Leverage
Operating CF-10.71M $
CapEx (TTM)4.34M $
FCF Margin8.26%
FCF Yield1.88%
Net Debt-445.25M $
Net Debt/EBITDA-588.96
Balance Sheet
Debt/Equity1.15
Current Ratio4.47
Quick Ratio4.15
Book Value/Sh8.155 USD
Cash/Share17.09 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.0 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)63.63 USD
Upside (mean)+75.8%
Target Range34.00 USD – 100.00 USD
$34.00+75.8% to mean$100.00
# Analysts11
Ownership
Shares Out.51.50M
Float45.83M
Insiders0.07%
Institutions102.95%
Short Interest
Short Ratio13.9d
Short % Float17.98%
Short % Out.16.16%
Shares Short8.22M
Short (prev mo.)8.99M
Technical
SMA 5032.72 (+10.6%)
SMA 20032.61 (+11.0%)
Beta0.74
S&P 52W Chg18.16%
Avg Vol (30d)465.85K
Avg Vol (10d)410.43K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—